Señales en vivo de 2252.HK | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 02:13):

Shanghai Microport Medbot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China and Europe...

Stats
Volumen de hoy	477 500
Volumen promedio	1.14M
Capitalización de mercado	14.15B
EPS	HKD0 ( 2024-03-29 )
Próxima fecha de ganancias	( HKD0 ) 2024-06-20
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-12.92
ATR14	HKD0.0360 (0.24%)

Volumen Correlación

Largo: 0.03 (neutral)

Corto: 0.45 (neutral)

Signal:(58.9) Neutral

Shanghai MicroPort MedBot Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Shanghai MicroPort MedBot Correlación - Moneda/Commodity

0.28
( neutral )

-0.07
( neutral )

0.00
( neutral )

-0.22
( neutral )

-0.13
( neutral )

Shanghai MicroPort MedBot Finanzas

Annual	2023
Ingresos:	HKD104.59M
Beneficio Bruto:	HKD14.69M (14.05 %)
EPS:	HKD-1.060

FY	2023
Ingresos:	HKD104.59M
Beneficio Bruto:	HKD14.69M (14.05 %)
EPS:	HKD-1.060

FY	2022
Ingresos:	HKD21.60M
Beneficio Bruto:	HKD6.56M (30.38 %)
EPS:	HKD-1.220

FY	2021
Ingresos:	HKD2.15M
Beneficio Bruto:	HKD919 000 (42.74 %)
EPS:	HKD-0.612

Financial Reports:

No articles found.

Shanghai MicroPort MedBot

Shanghai Microport Medbot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China and Europe. It offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; Honghu, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. The company also provides spine surgical robots; trans-bronchial surgical robots for trans-bronchial diagnosis and treatment; TAVR surgical robots for heart valve replacement surgery; and automated needle targeting robotics systems for percutaneous lung biopsy and percutaneous nephrolithotomy. Shanghai Microport Medbot (Group) Co., Ltd. was founded in 2014 and is based in Shanghai, China. Shanghai Microport Medbot (Group) Co., Ltd. operates as a subsidiary of MicroPort Scientific Corporation.